Hosted on MSN
Krystal Biotech projects EU and Japan launches for VYJUVEK in 2025, targeting $1B global peak sales
CEO Krish Krishnan highlighted 2024 as a strong year, driven by the continued success of the VYJUVEK launch in the U.S., which is tracking as a top-tier rare disease launch. He emphasized the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback